During the past decade, Copernicus Podmiot Leczniczy Sp. z o.o. conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Copernicus Podmiot Leczniczy Sp. z o.o." #1 sponsor was "Celgene" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Actelion" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "GlaxoSmithKline" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Copernicus Podmiot Leczniczy Sp. z o.o." #1 collaborator was "Syneos Health" with 2 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Copernicus Podmiot Leczniczy Sp. z o.o." are "Multiple Sclerosis" (6 trials), "Crohn Disease" (4 trials), "Colitis, Ulcerative" (3 trials), "Cervical Dystonia" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Copernicus Podmiot Leczniczy Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Copernicus Podmiot Leczniczy Sp. z o.o." are "Drug" (26 trials), "Other" (7 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ozanimod" (4 trials), "Deep Brain Stimulation (DBS)" (2 trials), "Ponesimod" (2 trials) and "0.25% albumin placebo solution with rHuPH20" (1 trials). Other intervention names were less common.

The vast majority of trials in "Copernicus Podmiot Leczniczy Sp. z o.o." are 32 trials for "All" genders.

Currently, there are NaN active trials in "Copernicus Podmiot Leczniczy Sp. z o.o.". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Copernicus Podmiot Leczniczy Sp. z o.o., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Copernicus Podmiot Leczniczy Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Copernicus Podmiot Leczniczy Sp. z o.o. has several departments that took part in Clinical trials: "Wojewodzkie Centrum Onkologii" - 27 trials, "COPERNICUS Podmiot Leczniczy Sp. z o. o. Szpital im. M. Kopernika; Oddział Neurologiczny" - 8 trials, "Copernicus Podmiot Leczniczy Sp. z o.o., Oddzial Dermatologii" - 2 trials, "Szpital Sw. Wojciecha; Oddzial Neurologiczny" - 2 trials